Characterization of natural suppressor cells in human bone marrow

Stem Cells
K SugiuraS Ikehara

Abstract

Natural suppressor (NS) cells, which exert nonspecific suppressive activity in an unprimed manner, have been found in mouse, rabbit and monkey bone marrow (BM). In the present study, we characterize NS cells in human BM. NS activity was found in a fraction of low density (1.055-1.065 g/ml) BM cells that had been depleted of T cells, B cells, and monocytes. The NS activity was significantly decreased by the depletion of CD34+ or CD33+ cells but not CD56+ cells. The NS activity was indeed detected in isolated CD34+ cells and further enriched in CD34+CD33+ cells. Hematopoietic progenitor cells committed to the myeloid lineage were also enriched in the CD34+CD33+ cells, which significantly correlated to the NS activity. From these findings, it is strongly suggested that NS activity in human BM is exerted by the myeloid hematopoietic progenitors. Since cell-to-cell contact was not necessary for the action, NS cells seemed to secrete soluble mediator(s). Transforming growth factor-beta 1 and leukemia inhibitory factor were, however, not the candidates, based on experiments using neutralizing antibodies.

References

Jan 1, 1990·Cytometry·S MiltenyiA Radbruch
Jan 1, 1991·Annals of the New York Academy of Sciences·A V MitasovV V Kozlov
Feb 1, 1989·European Journal of Haematology·H J BühringF W Busch
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·K SugiuraS Ikehara
Sep 15, 1987·Biochemical and Biophysical Research Communications·M Miyama-InabaS Ikehara
May 1, 1982·The American Journal of Anatomy·K Dorshkind, C Rosse
Feb 1, 1980·Cellular Immunology·J S CorveseS R Cooperband
Oct 1, 1986·Immunology Today·T MaierH N Claman

❮ Previous
Next ❯

Citations

Oct 7, 2000·Bulletin of Experimental Biology and Medicine·V V SenyukovV A Kozlov
Apr 17, 2008·International Journal of Cancer. Journal International Du Cancer·Rachid MarhabaMargot Zöller
Dec 13, 2006·Veterinary Immunology and Immunopathology·Viskam WijewardanaToshio Inaba
Sep 19, 2006·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·J A CampilloJ L Subiza

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.